Search stocks

Find any stock by ticker or company name

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Kuzatuv
Bozorlar
Kalendar
Skriner
Yangiliklar
Biz haqimizda

HSIC - Henry Schein, Inc. So'nggi Yangiliklar | Finranks

Home

/

HSIC

H

Henry Schein, Inc. (HSIC)

NMS – Real vaqt narxi. Valyuta: USD

90.59

+1.41 (1.58%)

Bozor ochiq: Aug 12, 2026, 3:03 PM EDT

89.18

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Here's Why Henry Schein (HSIC) is a Strong Momentum Stock

Here's Why Henry Schein (HSIC) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Should Value Investors Buy Henry Schein (HSIC) Stock?

Should Value Investors Buy Henry Schein (HSIC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

HSIC or SAUHY: Which Is the Better Value Stock Right Now?

HSIC or SAUHY: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Schein (HSIC) and Straumann Holding AG (SAUHY). But which of these two stocks presents investors with the better value opportunity right now?

Henry Schein, Inc. (HSIC) Hits Fresh High: Is There Still Room to Run?

Henry Schein, Inc. (HSIC) Hits Fresh High: Is There Still Room to Run?

Henry Schein (HSIC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call Transcript

Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call Transcript

Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call Transcript

Henry Schein Q2 Earnings Call Highlights

Henry Schein Q2 Earnings Call Highlights

Henry Schein NASDAQ: HSIC reported higher second-quarter sales, operating margins and earnings, citing accelerating internal sales growth, market-share gains in dental merchandise and early benefits from its value-creation program. The company also raised its full-year sales and adjusted earnings guidance.

HSIC Surpasses Q2 Earnings and Revenue Estimates, Stock Climbs

HSIC Surpasses Q2 Earnings and Revenue Estimates, Stock Climbs

Henry Schein tops Q2 earnings and revenue estimates as internal sales growth accelerates and management raises its 2026 outlook, lifting shares.

Videolar

No Data

There is no data to display

Press-relizlar

Henry Schein Reports Strong Second Quarter 2026 Financial Results and Raises FY2026 Guidance

Henry Schein Reports Strong Second Quarter 2026 Financial Results and Raises FY2026 Guidance

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, today reported financial results for the second quarter ended June 27, 2026. “We delivered strong sales performance and margin improvement in the second quarter, driven by sustained momentum across our businesses and solid operational execution by the team. Internal local currency sales growth accelerated compared to the first.